Replies to post #71778 on Biotech Values

[DewDiligence]

Re: HGSI / Albuferon monthly dosing

Are the PK calculations you posted for genotype-2/3 patients, specifically? The numbers for genotype-2/3 might be different from genotype-1, and this could explain why NVS/HGSI are pursuing monthly dosing for genotype-2/3 only.